{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T03:22:32Z","timestamp":1783740152058,"version":"3.55.0"},"reference-count":21,"publisher":"Japan Endocrine Society","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1507\/endocrj.ej24-0136","type":"journal-article","created":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T22:12:15Z","timestamp":1718835135000},"page":"955-963","source":"Crossref","is-referenced-by-count":4,"title":["Improving glycemic control by transitioning from the MiniMed&lt;sup&gt;TM&lt;\/sup&gt; 640G to 770G in Japanese adults with type 1 diabetes mellitus: a prospective, single-center, observational study"],"prefix":"10.1507","volume":"71","author":[{"given":"Satoshi","family":"Kubota","sequence":"first","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"},{"name":"Center of Diabetes, Okaya City Hospital, Okaya 394-8512, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manami","family":"Hosokawa","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okubo","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shohei","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuho","family":"Shimada","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Asano","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiko","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"},{"name":"Internal of Medicine, Matsumoto City Hospital, Matsumoto 390-1401, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1359-9732","authenticated-orcid":false,"given":"Mitsuhisa","family":"Komatsu","sequence":"additional","affiliation":[{"name":"Department of Diabetes, Endocrinology and Metabolism, Division of Internal Medicine, Shinshu University School of Medicine, Matsumoto 390-8621, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Wilson LM, Castle JR (2020 ) Recent advances in insulin therapy. Diabetes Technol Ther 22: 929\u2013936.","DOI":"10.1089\/dia.2020.0065"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Beck RW, Bergenstal RM, Laffel LM, Pickup JC (2019) Advances in technology for management of type 1 diabetes. Lancet 394: 1265\u20131273.","DOI":"10.1016\/S0140-6736(19)31142-0"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Phillip M, Nimri R, Bergenstal RM, Barnard-Kelly K, Danne T, et al. (2023) Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 44: 254\u2013280.","DOI":"10.1210\/endrev\/bnac022"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, et al. (2010) Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 363: 311\u2013320.","DOI":"10.1056\/NEJMoa1002853"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Forlenza GP, Li Z, Buckingham BA, Pinsker JE, Cengiz E, et al. (2018) Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial. Diabetes Care 41: 2155\u20132161.","DOI":"10.2337\/dc18-0771"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Tsunemi A, Sato J, Kurita M, Wakabayashi Y, Waseda N, et al. (2020) Effect of real-life insulin pump with predictive low-glucose management use for 3 months: analysis of the patients treated in a Japanese center. J Diabetes Investig 11: 1564\u20131569.","DOI":"10.1111\/jdi.13288"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Collyns OJ, Meier RA, Betts ZL, Chan DSH, Frampton C, et al. (2021) Improved glycemic outcomes with Medtronic MiniMed advanced hybrid closed-loop delivery: results from a randomized crossover trial comparing automated insulin delivery with predictive low glucose suspend in people with type 1 diabetes. Diabetes Care 44: 969\u2013975.","DOI":"10.2337\/dc20-2250"},{"key":"8","unstructured":"8 Ishii H, Bradley C, Riazi A, Barendse S, Yamamoto T (2000) The Japanese version of the diabetes treatment satisfaction questionnaire (DTSQ): translation and clinical evaluation. J Clin Exp Med 192: 809\u2013814 (In Japanese)."},{"key":"9","unstructured":"9 Bradley C (1994) The diabetes treatment satisfaction questionnaire (DTSQ). In: Bradley C (ed) Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice. Harwood Academic Publishers, Chul, Switzerland: 111\u2013132."},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, et al. (1995) Assessment of diabetes-related distress. Diabetes Care 18: 754\u2013760.","DOI":"10.2337\/diacare.18.6.754"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Hayashino Y, Goto M, Yamamoto T, Tsujii S, Ishii H (2023) The Japanese version of problem areas in diabetes scale: a clinical and research tool to assess emotional functioning among people with diabetes. Diabetol Int 15: 117\u2013122.","DOI":"10.1007\/s13340-023-00661-x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Sakane N, Murata T, Tone A, Kato K, Kimura M, et al. (2020) Development and validation of the continuous subcutaneous insulin infusion-related quality-of-life (CSII-QOL) scale. Diabetes Technol Ther 22: 216\u2013221.","DOI":"10.1089\/dia.2019.0216"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Da Silva J, Bosi E, Jendle J, Arrieta A, Castaneda J, et al. (2021) Real-world performance of the MiniMed<sup>TM<\/sup> 670G system in Europe. Diabetes Obes Metab 23: 1942\u20131949.","DOI":"10.1111\/dom.14424"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Brown SA, Kovatchev BP, Raghinaru D, Lum JW, Buckingham BA, et al. (2019) Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes. N Engl J Med 381: 1707\u20131717.","DOI":"10.1056\/NEJMoa1907863"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Benhamou PY, Franc S, Reznik Y, Thivolet C, Schaepelynck P, et al. (2019) Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. Lancet Digit Health 1: e17\u2013e25.","DOI":"10.1016\/S2589-7500(19)30003-2"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Akiyama T, Yamakawa T, Orime K, Ichikawa M, Harada M, et al. (2024) Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: a prospective single-center observational study. J Diabetes Investig 15: 219\u2013226.","DOI":"10.1111\/jdi.14103"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 McAuley SA, Lee MH, Paldus B, Vogrin S, de Bock MI, et al. (2020) Six months of hybrid closed-loop <i>versus<\/i> manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial. Diabetes Care 43: 3024\u20133033.","DOI":"10.2337\/db20-999-P"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Farrington C (2018) Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review. Diabet Med 35: 436\u2013449.","DOI":"10.1111\/dme.13567"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Battelino T, Alexander CM, Amiel SA, Arreaza-Rubin G, Beck RW, et al. (2023) Continuous glucose monitoring and metrics for clinical trials: an international consensus statement. Lancet Diabetes Endocrinol 11: 42\u201357.","DOI":"10.1016\/S2213-8587(22)00319-9"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Graham R, Mueller L, Manning M, Habif S, Messer LH, et al. (2024) Real-world use of control-IQ technology is associated with a lower rate of severe hypoglycemia and diabetic ketoacidosis than historical data: results of the control-IQ observational (CLIO) prospective study. Diabetes Technol Ther 26: 24\u201332.","DOI":"10.1089\/dia.2023.0341"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kesavadev J, Basanth A, Krishnan G, Shankar A, Sanal G, et al. (2023) Real-world user and clinician perspective and experience with MiniMed<sup>TM<\/sup> 780G advanced hybrid closed loop system. Diabetes Ther 14: 1319\u20131330.","DOI":"10.1007\/s13300-023-01427-z"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/10\/71_EJ24-0136\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T04:12:52Z","timestamp":1728101572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/71\/10\/71_EJ24-0136\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej24-0136","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"EJ24-0136"}}